Rowe Lab

@RoweLab_aus

Molecular imaging lab investigating biomarkers (PET & blood) for neurodegenerative diseases, focusing on early detection & therapeutic intervention in AD.

Melbourne, Australia Joined August 2022

304 Following 145 Followers 40 Posts

Latest posts 5

Rowe Lab @RoweLab_aus Oct 28, 2024

Exciting news! Our findings on the Lumipulse #pTau217 assay were featured in @theheraldsun and @dailytelegraph. In this interview, Prof. Christopher Rowe explains the difference this blood test could make for #Alzheimers diagnosis.

Have a read here: dailytelegraph.com.au/news/victoria/…

Azadeh Feizpour @AzadehFeizpour Oct 22, 2024

Pleased to present our paper @eBioMedicine, on the Lumipulse plasma pTau217 assay.

Lumipulse-G platform → large global installation base in clinical pathology services → better access/uptake of plasma #ptau217 into clinical practice.

Link: doi.org/10.1016/j.ebio…
#Alzheimers
View quoted post on X

Rowe Lab @RoweLab_aus Jul 27, 2024

We at Rowe Lab are very proud that our PET expert, @vincentDore2 was awarded the prestigious de Leon Prize, as senior author of “CenTauR: Toward a universal scale and masks for standardizing tau imaging studies”. Time to celebrate this great achievement! #AAIC24 #AIC

Rowe Lab @RoweLab_aus Jan 29, 2024

Trials are currently in progress for #Alzheimer's blood tests in Australia. Tune in to our interview on @7NewsMelbourne to stay informed and contribute to the journey against Alzheimer's. #Alzheimers #Research #Dementia #DementiaAwareness

The Florey @TheFlorey Jan 29, 2024

#ICYMI

Professor Chris Rowe, Clinical Lead in the Florey's Dementia Mission, spoke to @7NewsMelbourne about the efficacy of a potential new blood test that can detect early signs of Alzheimer's.

In collaboration with @Austin_Health @ADNeT_Australia
& @UniMelb

View quoted post on X

Rowe Lab @RoweLab_aus Oct 11, 2023

🔥 Hot off the press: our new article on VMAT2 PET as a sensitive tool to detect and quantify Parkinson’s disease (PD) progression over two years.🧠
This is a breakthrough discovery with implications for PD diagnostics and clinical trials.
#Neuroscience #Parkinsons

Vincent Dore @vincentDore2 Oct 11, 2023

🔥 Hot off the press: Utilizing 18F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease
#neurology #parkinsons #biomarker #PET #NeuroTwitter n.neurology.org/content/early/…

View quoted post on X

Rowe Lab @RoweLab_aus Oct 6, 2023

Check out the paper by our collaborator, @YingXia87, on changes in basal forebrain in normal aging and Alzheimer’s disease.

Ying Xia @YingXia87 Oct 5, 2023

🧠 How does the basal forebrain change in normal aging and Alzheimer’s disease? 🧠

Check out our new paper that reveals the patterns of volume loss in the cholinergic system over 14 years in 516 old adults from AIBL.

#ENDALZ #Alzheimers

sciencedirect.com/science/articl…
View quoted post on X